Skip to main content
. Author manuscript; available in PMC: 2015 Apr 26.
Published in final edited form as: Am J Transplant. 2012 Jun 8;12(9):2526–2531. doi: 10.1111/j.1600-6143.2012.04126.x

Table 4.

Previous reports of acute antibody-mediated rejection in ABO-compatible liver transplants

Author, year N C4d DSA Onset (PTD) Treatment Patient outcome
Kamar, 2009 (3) 2 + + 6 PP, rituximab 1 survived, 1 died
Wilson, 2006 (13) 1 + + 1460 PP, Thymoglobulin, rituximab Survived
Watson, 2006 (4) 1 + + 1 PP, rituximab, steroids Died
Rostron, 2005 (11) 1 +/− + 6 PP, steroids, IVIG, mycophenolate Survived
Kozlowski, 2011 (5) 3 + + 1 PP, rituximab, steroids, IVIG, Thymoglobulin, OKT-3 2 died, 1 retransplant

N = number of patients; DSA = donor-specific antibodies; PTD = posttransplant day; PP = plasmapheresis; IVIG = intravenous immunoglobulins.